An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess. by Bentley, L, Esapa, C, Nesbit, M, Head, R, Evans, H, Lath, D, Scudamore, C, Hough, T, Podrini, C, Hannan, F, Fraser, W, Croucher, P, Brown, M, Brown, S, Cox, R, Thakker, R

An N-ethyl-n-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess by Bentley, L, Esapa, C, Nesbit, M, Head, R, Evans, H, Lath, D, Scudamore, C, Hough, T, Podrini, C, Hannan, F, Fraser, W, Croucher, P, Brown, M, Brown, S, Cox, R, Thakker, R

The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate) by Lawson, M, Ebetino, F, Mazur, A, Chantry, A, Paton-Hough, J, Evans, H, Lath, D, Tsoumpra, M, Lundy, M, Dobson, R, Quijano, M, Kwaasi, A, Dunford, J, Duan, X, Triffitt, J, Jeans, G, Russell, R